HQL

MKT CAP:$535M

Tekla Life Sciences Investors

Market Cap

$535M

Financial Services·Asset Management·🇺🇸 United States·NYSE

Financials·Asset Management·🇺🇸·NYSE

Stock Price

$16.92+$1.20 (+7.66%)

Jun 5, 2026

52W High $17.8652W Low $11.00

Company Details

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences secto...

CEO

—

IPO Date

May 4, 1992

Website

www.teklacap.com/hql.html

Key Metrics TTM

Revenue

$34M

+0.8% YoY

Net Income

$171M

EPS (Diluted)

Free Cash Flow

-$2M

Revenue / Share

$1.17

Gross Margin

38.9%

Operating Margin

247.5%

Net Margin

505.4%

FCF Margin

-6.9%

P/S

15.8x

P/E

3.1x

Earnings Reports

FY 2025

Dec 8, 2025

$86M-0.3%

Q4 2025

Dec 8, 2025

$12M+507.6%

Q2 2025

Jun 9, 2025

$18M+781.2%

FY 2024

Dec 9, 2024

$87M+268.5%

Q4 2024

Dec 9, 2024

$2M-93.5%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

OpEx Breakdown

War Chest

Shares Outstanding